Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal, and rectal prostaglandin levels and on mucosal injury in healthy humans
- 1 July 1999
- journal article
- clinical trial
- Published by Elsevier in Gastroenterology
- Vol. 117 (1) , 17-25
- https://doi.org/10.1016/s0016-5085(99)70545-7
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Effects of aging and gastritis on gastric acid and pepsin secretion in humans: A prospective studyGastroenterology, 1996
- Interaction of NSAIDs and Helicobacter pylori on gastrointestinal injury and prostaglandin production: a controlled double‐blind trialAlimentary Pharmacology & Therapeutics, 1995
- Interrelationships betweenHelicobacter pylori infection, nonsteroidal antiinflammatory drugs and gastroduodenal diseaseDigestive Diseases and Sciences, 1994
- Prevalence of Helicobacter pylori infection and its effect on symptoms and non-steroidal anti-inflammatory drug induced gastrointestinal damage in patients with rheumatoid arthritis.Gut, 1993
- Proctitis and Rectal Stenosis Induced by Nonsteroidal Antiinflammatory SuppositoriesJournal of Clinical Gastroenterology, 1993
- Reduced Risk of Large-Bowel Adenomas Among Aspirin UsersJNCI Journal of the National Cancer Institute, 1993
- Swedish Aspirin Low-dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic eventsThe Lancet, 1991
- Final Report on the Aspirin Component of the Ongoing Physicians' Health StudyNew England Journal of Medicine, 1989
- Aspirin in Cardiovascular DiseaseDrugs, 1988
- COMPARISON OF THE EFFECTS OF REGULAR AND ENTERIC-COATED ASPIRIN ON GASTRODUODENAL MUCOSA OF MANThe Lancet, 1980